213 related articles for article (PubMed ID: 20826493)
1. Review of cancer pain management in patients receiving maintenance methadone therapy.
Rowley D; McLean S; O'Gorman A; Ryan K; McQuillan R
Am J Hosp Palliat Care; 2011 May; 28(3):183-7. PubMed ID: 20826493
[TBL] [Abstract][Full Text] [Related]
2. Opioid rotation in patients with cancer pain. A retrospective comparison of dose ratios between methadone, hydromorphone, and morphine.
Bruera E; Pereira J; Watanabe S; Belzile M; Kuehn N; Hanson J
Cancer; 1996 Aug; 78(4):852-7. PubMed ID: 8756381
[TBL] [Abstract][Full Text] [Related]
3. Methadone versus morphine as a first-line strong opioid for cancer pain: a randomized, double-blind study.
Bruera E; Palmer JL; Bosnjak S; Rico MA; Moyano J; Sweeney C; Strasser F; Willey J; Bertolino M; Mathias C; Spruyt O; Fisch MJ
J Clin Oncol; 2004 Jan; 22(1):185-92. PubMed ID: 14701781
[TBL] [Abstract][Full Text] [Related]
4. Management of acute pain in methadone maintenance therapy in-patients.
Hines S; Theodorou S; Williamson A; Fong D; Curry K
Drug Alcohol Rev; 2008 Sep; 27(5):519-23. PubMed ID: 18696299
[TBL] [Abstract][Full Text] [Related]
5. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
[TBL] [Abstract][Full Text] [Related]
6. Intermittent subcutaneous methadone administration in the management of cancer pain.
Centeno C; Vara F
J Pain Palliat Care Pharmacother; 2005; 19(2):7-12. PubMed ID: 16061456
[TBL] [Abstract][Full Text] [Related]
7. Methadone: an effective alternative to morphine for pain relief in cancer patients.
Shelton BW; Deynes-Romero J; Tofani-Montalvo M; Ramírez-Rivera J; Jaumne-Anselmi F
Bol Asoc Med P R; 2008; 100(3):7-10. PubMed ID: 19227708
[TBL] [Abstract][Full Text] [Related]
8. The differential effect of methadone dose and of chronic pain on pain perception of former heroin addicts receiving methadone maintenance treatment.
Peles E; Schreiber S; Hetzroni T; Adelson M; Defrin R
J Pain; 2011 Jan; 12(1):41-50. PubMed ID: 20561825
[TBL] [Abstract][Full Text] [Related]
9. Morphine-methadone opioid rotation in cancer patients: analysis of dose ratio predicting factors.
Benítez-Rosario MA; Salinas-Martín A; Aguirre-Jaime A; Pérez-Méndez L; Feria M
J Pain Symptom Manage; 2009 Jun; 37(6):1061-8. PubMed ID: 19171458
[TBL] [Abstract][Full Text] [Related]
10. A matched comparison study of medical and psychiatric complications and anesthesia and analgesia requirements in methadone-maintained liver transplant recipients.
Weinrieb RM; Barnett R; Lynch KG; DePiano M; Atanda A; Olthoff KM
Liver Transpl; 2004 Jan; 10(1):97-106. PubMed ID: 14755785
[TBL] [Abstract][Full Text] [Related]
11. Dose ratio between morphine and methadone in patients with cancer pain: a retrospective study.
Lawlor PG; Turner KS; Hanson J; Bruera ED
Cancer; 1998 Mar; 82(6):1167-73. PubMed ID: 9506365
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the early pharmacodynamic profile of oral methadone for cancer-related breakthrough pain: a pilot study.
Fisher K; Stiles C; Hagen NA
J Pain Symptom Manage; 2004 Dec; 28(6):619-25. PubMed ID: 15589088
[TBL] [Abstract][Full Text] [Related]
13. Methadone: does stigma play a role as a barrier to treatment of chronic pain?
Shah S; Diwan S
Pain Physician; 2010; 13(3):289-93. PubMed ID: 20495594
[TBL] [Abstract][Full Text] [Related]
14. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
15. MMTP patients with chronic pain switching to pain management clinics. A problem or an acceptable practice?
Cruciani RA; Esteban S; Seewald RM; Altilio T; Bookbinder M; Sheu R; Portenoy RK
Pain Med; 2008 Apr; 9(3):359-64. PubMed ID: 18366514
[TBL] [Abstract][Full Text] [Related]
16. Role of methadone in the management of pain in cancer patients.
Bruera E; Neumann CM
Oncology (Williston Park); 1999 Sep; 13(9):1275-82; discussion 1285-8, 1291. PubMed ID: 10509323
[TBL] [Abstract][Full Text] [Related]
17. Methadone as an analgesic: a review of the risks and benefits.
Terpening CM; Johnson WM
W V Med J; 2007; 103(1):14-8. PubMed ID: 17432310
[TBL] [Abstract][Full Text] [Related]
18. [Cancer-related pain].
Lundorff LE; Eriksen J; Sjøgren P
Ugeskr Laeger; 2006 May; 168(20):1960-2. PubMed ID: 16768893
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and pharmacodynamics of methadone enantiomers in hospice patients with cancer pain.
Auret K; Roger Goucke C; Ilett KF; Page-Sharp M; Boyd F; Oh TE
Ther Drug Monit; 2006 Jun; 28(3):359-66. PubMed ID: 16778720
[TBL] [Abstract][Full Text] [Related]
20. Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain.
Benítez-Rosario MA; Feria M; Salinas-Martín A; Martínez-Castillo LP; Martín-Ortega JJ
Cancer; 2004 Dec; 101(12):2866-73. PubMed ID: 15529307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
